Search:
Tokushima University > Institute of Advanced Medical Sciences > オープンイノベーション領域 > (CSV files for researchmap) [PDF manual]

Research Activity

Field of Study

Endocrinology

Subject of Study

Mineral metabolism, Bone metabolism, Calciotropic hormone, Phosphotropic hormone (Fibroblast growth factor 23, Calcium-sensing receptor, Vitamin D, Parathyroid hormone)

Book / Paper

Book:

1. Seiji Fukumoto :
Fibroblast growth factor 23,
Academic Press, Aug. 2019.
2. Seiji Fukumoto :
Phosphate Metabolism, Hyperphosphatemia, and Hypophosphatemia,
Academic Press, Oxford, Oct. 2018.
3. Sumiko Yoshida and Seiji Fukumoto :
薬を飲んでも血圧が下がりません,
Nankodo, Tokyo, Apr. 2017.

Academic Paper (Judged Full Paper):

1. Seiji Fukumoto, Yuichi Takashi, Maria Tsoumpra, Shun Sawatsubashi and Toshio Matsumoto :
How do we sense phosphate to regulate serum phosphate level?,
Journal of Bone and Mineral Metabolism, 2019.
(DOI: 10.1007/s00774-019-01066-0,   PubMed: 31797064)
2. Seiji Fukumoto :
FGF23 and Bone and Mineral Metabolism.,
Handbook of Experimental Pharmacology, 2019.
(DOI: 10.1007/164_2019_330,   PubMed: 31792685)
3. Chang Liu, Zhen Zhao, Ou Wang, Mei Li, Xiaoping Xing, Evelyn Hsieh, Seiji Fukumoto, Yan Jiang and Weibo Xia :
Earlier Onset in Autosomal Dominant Hypophosphatemic Rickets of R179 than R176 Mutations in Fibroblast Growth Factor 23: Report of 20 Chinese Cases and Review of the Literature.,
Calcified Tissue International, Vol.105, No.5, 476-486, 2019.
(DOI: 10.1007/s00223-019-00597-y,   PubMed: 31486862)
4. Yuichi Takashi, Shu Wakino, Hitoshi Minakuchi, Masashi Ishizu, Akio Kuroda, Hisato Shima, Manabu Tashiro, Keiko Miya, Kazuyoshi Okada, Jun Minakuchi, Shu Kawashima, Munehide Matsuhisa, Toshio Matsumoto and Seiji Fukumoto :
Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients.,
Journal of Bone and Mineral Metabolism, Vol.38, No.1, 70-77, 2019.
(DOI: 10.1007/s00774-019-01027-7,   PubMed: 31420749)
5. Maria Tsoumpra, Seiji Fukumoto, Toshio Matsumoto, Shin'ichi Takeda, Matthew J. A. Wood and Yoshitsugu Aoki :
Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases.,
EBioMedicine, Vol.45, 630-645, 2019.
(DOI: 10.1016/j.ebiom.2019.06.036,   PubMed: 31257147)
6. Yuichi Takashi, Hidetaka Kosako, Shun Sawatsubashi, Yuka Kinoshita, Nobuaki Ito, Maria K. Tsoumpra, Masaomi Nangaku, Masahiro Abe, Munehide Matsuhisa, Shigeaki Kato, Toshio Matsumoto and Seiji Fukumoto :
Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation,
Proceedings of the National Academy of Sciences of the United States of America, Vol.116, No.23, 11418-11427, 2019.
(Tokushima University Institutional Repository: 113621,   DOI: 10.1073/pnas.1815166116,   PubMed: 31097591)
7. Dong Bingzi, Itsuro Endo, Ohnishi Yukoyo, Mitsui Yukari, Kiyoe Kurahashi, Mai Kanai, Masahiro Hiasa, Jumpei Teramachi, Hirofumi Tenshin, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
Persistent Activation of Calcium-Sensing Receptor Suppresses Bone Turnover, Increases Microcracks, and Decreases Bone Strength.,
JBMR Plus, Vol.3, No.7, e10182, 2019.
(DOI: 10.1002/jbm4.10182,   PubMed: 31372589)
8. Yuka Kinoshita, Yuichi Takashi, Nobuaki Ito, Shiro Ikegawa, Hiroyuki Mano, Tetsuo Ushiku, Masashi Fukayama, Masaomi Nangaku and Seiji Fukumoto :
Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO).,
Bone Reports, Vol.10, 100192, 2018.
(Tokushima University Institutional Repository: 113624,   DOI: 10.1016/j.bonr.2018.100192,   PubMed: 30627598)
9. Yuichi Takashi and Seiji Fukumoto :
FGF23 beyond Phosphotropic Hormone.,
Trends in Endocrinology and Metabolism, Vol.29, No.11, 755-767, 2018.
(DOI: 10.1016/j.tem.2018.08.006,   PubMed: 30217676)
10. Takuo Kubota, Hirofumi Nakayama, Taichi Kitaoka, Yosikazu Nakamura, Seiji Fukumoto, Ikuma Fujiwara, Yukihiro Hasegawa, Kenji Ihara, Sachiko Kitanaka, Satomi Koyama, Satoshi Kusuda, Haruo Mizuno, Keisuke Nagasaki, Koji Oba, Yuko Sakamoto, Noriyuki Takubo, Toshiaki Shimizu, Yusuke Tanahashi, Kosei Hasegawa, Hirokazu Tsukahara, Tohru Yorifuji, Toshimi Michigami and Keiichi Ozono :
Incidence rate and characteristics of symptomatic vitamin D deficiency in children: a nationwide survey in Japan.,
Endocrine Journal, 2018.
(DOI: 10.1507/endocrj.EJ18-0008,   PubMed: 29526992)
11. Shun Sawatsubashi, Yudai Joko, Seiji Fukumoto, Toshio Matsumoto and Shigeo S. Sugano :
Development of versatile non-homologous end joining-based knock-in module for genome editing.,
Scientific Reports, Vol.8, No.1, 593, 2018.
(Tokushima University Institutional Repository: 112400,   DOI: 10.1038/s41598-017-18911-9,   PubMed: 29330493,   Elsevier: Scopus)
12. Hiroshi Kobayashi, Toru Akiyama, Tomotake Okuma, Yusuke Shinoda, Hiroyuki Oka, Nobuaki Ito, Seiji Fukumoto, Sakae Tanaka and Hirotaka Kawano :
Three-dimensional fluoroscopic navigation-assisted surgery for tumors in patients with tumor-induced osteomalacia in the bones.,
Computer Assisted Surgery, Vol.22, No.1, 14-19, 2017.
(DOI: 10.1080/24699322.2017.1282044,   PubMed: 28081649)
13. Hiroshi Kobayashi, Nobuaki Ito, Toru Akiyama, Tomotake Okuma, Yuka Kinoshita, Masachika Ikegami, Yusuke Shinoda, Seiji Fukumoto, Sakae Tanaka and Hirotaka Kawano :
Prevalence and clinical outcomes of hip fractures and subchondral insufficiency fractures of the femoral head in patients with tumour-induced osteomalacia.,
International Orthopaedics, Vol.41, No.12, 2597-2603, 2017.
(DOI: 10.1007/s00264-017-3610-3,   PubMed: 28836028,   Elsevier: Scopus)
14. Kiyoe Kurahashi, Itsuro Endo, Takeshi Kondo, Kana Morimoto, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Kohhei Nakajima, Yoshifumi Mizobuchi, Shinji Nagahiro, Masahiro Abe and Seiji Fukumoto :
Remarkable Shrinkage of a Growth Hormone (GH)-secreting Macroadenoma Induced by Somatostatin Analogue Administration: A Case Report and Literature Review.,
Internal Medicine, Vol.56, No.18, 2455-2461, 2017.
(DOI: 10.2169/internalmedicine.8223-16,   PubMed: 28824054,   Elsevier: Scopus)
15. Ryuichi Watanabe, Nobuyuki Fujita, Yuiko Sato, Tami Kobayashi, Mayu Morita, Takatsugu Oike, Kana Miyamoto, Makoto Kuro-O, Toshimi Michigami, Seiji Fukumoto, Takashi Tsuji, Yoshiaki Toyama, Masaya Nakamura, Morio Matsumoto and Takeshi Miyamoto :
Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions.,
Scientific Reports, Vol.7, No.1, 7786, 2017.
(Tokushima University Institutional Repository: 112398,   DOI: 10.1038/s41598-017-07341-2,   PubMed: 28798354)
16. Taijun Hana, Shota Tanaka, Hirofumi Nakatomi, Masaaki Shojima, Seiji Fukumoto, Masako Ikemura and Nobuhito Saito :
Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the half-life of serum fibroblast growth factor 23.,
Endocrine Journal, Vol.64, No.10, 1033-1039, 2017.
(DOI: 10.1507/endocrj.EJ17-0177,   PubMed: 28768937)
17. Salvatore Minisola, Munro Peacock, Seiji Fukumoto, Cristiana Cipriani, Jessica Pepe, Harsha Sri Tella and T Michael Collins :
Tuour-induced osteomalacia,
Nature Reviews. Disease Primers, Vol.3, 17004, 2017.
(DOI: 10.1038/nrdp.2017.44,   PubMed: 28703220)
18. Yuka Kinoshita, Nobuaki Ito, Noriko Makita, Masaomi Nangaku and Seiji Fukumoto :
Changes in bone metabolic parameters following oral calcium supplementation in an adult patient with vitamin D-dependent rickets type 2A.,
Endocrine Journal, Vol.64, No.6, 589-596, 2017.
(DOI: 10.1507/endocrj.EJ16-0583,   PubMed: 28367941)
19. Yuichi Takashi, Yuka Kinoshita, Nobuaki Ito, Manabu Taguchi, Masaaki Takahashi, Naoya Egami, Shogo Tajima, Masaomi Nangaku and Seiji Fukumoto :
Tumor-induced Osteomalacia Caused by a Parotid Tumor.,
Internal Medicine, Vol.56, No.5, 535-539, 2017.
(DOI: 10.2169/internalmedicine.56.7565,   PubMed: 28250301)
20. Takeshi Kondo, Itsuro Endo, Yukari Ooguro, Kana Morimoto, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto :
Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer.,
Internal Medicine, Vol.55, No.24, 3623-3626, 2016.
(DOI: 10.2169/internalmedicine.55.7359,   PubMed: 27980263,   Elsevier: Scopus)
21. Yuichi Takashi, Yuka Kinoshita, Michiko Hori, Nobuaki Ito, Manabu Taguchi and Seiji Fukumoto :
Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.,
Endocrine Research, Vol.42, No.2, 132-137, 2016.
(DOI: 10.1080/07435800.2016.1242604,   PubMed: 27754732)
22. Takeshi Kondo, Itsuro Endo, Ken-ichi Aihara, Ohnishi Yukiyo, Dong Bingzi, Oguro Yukari, Kiyoe Kurahashi, Sumiko Yoshida, Yuichi Fujinaka, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Toshio Matsumoto and Masahiro Abe :
Serum carboxy-terminal telopeptide of type I collagen levels are associated with carotid atherosclerosis in patients with cardiovascular risk factors.,
Endocrine Journal, Vol.63, No.4, 397-404, 2016.
(DOI: 10.1507/endocrj.EJ15-0589,   PubMed: 26877258,   Elsevier: Scopus)
23. Yuka Kinoshita, Makoto Arai, Nobuaki Ito, Yuichi Takashi, Noriko Makita, Masaomi Nangaku, Yusuke Shinoda and Seiji Fukumoto :
High serum ALP level is associated with increased risk of denosumab-related hypocalcemia in patients with bone metastases from solid tumors.,
Endocrine Journal, Vol.63, No.5, 479-484, 2016.
(DOI: 10.1507/endocrj.EJ16-0003,   PubMed: 26860123,   Elsevier: Scopus)
24. Yuichi Takashi, Yuka Kinoshita, Noriko Makita, Manabu Taguchi, Katsutoshi Takahashi, Masaomi Nangaku and Seiji Fukumoto :
Rapid Recovery of Hypothalamic-Pituitary Axis after Successful Resection of an ACTH-secreting Neuroendocrine Tumor.,
Internal Medicine, Vol.54, No.17, 2201-2205, 2015.
(DOI: 10.2169/internalmedicine.54.4915,   PubMed: 26328647,   Elsevier: Scopus)
25. Seiji Fukumoto, Keiichi Ozono, Toshimi Michigami, Masanori Minagawa, Ryo Okazaki, Toshitsugu Sugimoto, Yasuhiro Takeuchi and Toshio Matsumoto :
Pathogenesis and diagnostic criteria for rickets and osteomalacia-proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society.,
Journal of Bone and Mineral Metabolism, Vol.33, No.5, 467-473, 2015.
(DOI: 10.1007/s00774-015-0698-7,   PubMed: 26197863,   Elsevier: Scopus)
26. Bingzi Dong, Itsuro Endo, Yukiyo Ohnishi, Takeshi Kondo, Tomoka Hasegawa, Norio Amizuka, Hiroshi Kiyonari, Go Shioi, Masahiro Abe, Seiji Fukumoto and Toshio Matsumoto :
Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).,
Journal of Bone and Mineral Research, Vol.30, No.11, 1980-1993, 2015.
(DOI: 10.1002/jbmr.2551,   PubMed: 25967373,   Elsevier: Scopus)
27. Seiji Fukumoto :
FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.,
Calcified Tissue International, Vol.98, No.4, 334-340, 2015.
(DOI: 10.1007/s00223-015-0029-y,   PubMed: 26126937)
28. Itsuro Endo, Seiji Fukumoto, Keiichi Ozono, Noriyuki Namba, Daisuke Inoue, Ryo Okazaki, Mika Yamauchi, Toshitsugu Sugimoto, Masanori Minagawa, Toshimi Michigami, Masaki Nagai and Toshio Matsumoto :
Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment.,
Endocrine Journal, Vol.62, No.9, 811-816, 2015.
(DOI: 10.1507/endocrj.EJ15-0275,   PubMed: 26135520,   Elsevier: Scopus)
29. Shogo Tajima, Yuichi Takashi, Nobuaki Ito, Seiji Fukumoto and Masashi Fukuyama :
ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors.,
Medical Molecular Morphology, 2015.
(DOI: 10.1007/s00795-015-0115-2,   PubMed: 26122367,   Elsevier: Scopus)
30. Michiko Hori, Yuka Kinoshita, Manabu Taguchi and Seiji Fukumoto :
Phosphate enhances Fgf23 expression through reactive oxygen species in UMR-106 cells.,
Journal of Bone and Mineral Metabolism, Vol.34, No.2, 132-139, 2015.
(DOI: 10.1007/s00774-015-0651-9,   PubMed: 25792238,   Elsevier: Scopus)
31. Tomofumi Okamiya, Katsumasa Takahashi, Hideo Kamada, Junko Hirato, Toru Motoi, Seiji Fukumoto and Kazuaki Chikamatsu :
Oncogenic osteomalacia caused by an occult paranasal sinus tumor.,
Auris, Nasus, Larynx, Vol.42, No.2, 167-169, 2015.
(DOI: 10.1016/j.anl.2014.10.001,   PubMed: 25682388,   Elsevier: Scopus)
32. Yuka Kinoshita, Michiko Hori, Manabu Taguchi and Seiji Fukumoto :
Functional analysis of mutant FAM20C in Raine syndrome with FGF23-related hypophosphatemia.,
Bone, Vol.67, 145-151, 2014.
(DOI: 10.1016/j.bone.2014.07.009,   PubMed: 25026495)
33. Seiji Fukumoto :
What can FGF23 do without Klotho?,
BoneKEy Reports, Vol.3, 551, 2014.
(DOI: 10.1038/bonekey.2014.46,   PubMed: 25120908)
34. Seiji Fukumoto :
Anti-fibroblast growth factor 23 antibody therapy.,
Current Opinion in Nephrology and Hypertension, Vol.23, No.4, 346-351, 2014.
(DOI: 10.1097/01.mnh.0000447012.98357.da,   PubMed: 24848934)
35. Shinji Takeyari, Takehisa Yamamoto, Yuka Kinoshita, Seiji Fukumoto, H Francis Glorieux, Toshimi Michigami, Kosei Hasegawa, Taichi Kitaoka, Takuo Kubota, Yasuo Imanishi, Tsunesuke Shimotsuji and Keiichi Ozono :
Hypophosphatemic osteomalacia and bone sclerosis caused by a novel homozygous mutation of the FAM20C gene in an elderly man with a mild variant of Raine syndrome.,
Bone, Vol.67, 56-62, 2014.
(DOI: 10.1016/j.bone.2014.06.026,   PubMed: 24982027)
36. Seiji Fukumoto :
Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia.,
Endocrinology and Metabolism, Vol.29, No.2, 136-143, 2014.
(DOI: 10.3803/EnM.2014.29.2.136,   PubMed: 25031885)
37. Takeshi Nakamura, Toshimi Aizawa, Takeshi Hoshikawa, Hiroshi Ozawa, Nobuaki Ito, Seiji Fukumoto, Eiji Itoi and Shoichi Kokubun :
Tumor-induced osteomalacia caused by phosphaturic mesenchymal tumor of the cervical spine.,
Journal of Orthopaedic Science, Vol.20, No.4, 765-771, 2014.
(DOI: 10.1007/s00776-014-0540-4,   PubMed: 24504987,   Elsevier: Scopus)
38. Seiji Fukumoto :
Phosphate metabolism and vitamin D.,
BoneKEy Reports, Vol.3, 497, 2014.
(DOI: 10.1038/bonekey.2013.231,   PubMed: 24605214)
39. Yuka Kinoshita, Michiko Hori, Manabu Taguchi, Sumiyo Watanabe and Seiji Fukumoto :
Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.,
The Journal of Clinical Endocrinology and Metabolism, Vol.99, No.2, E363-8, 2013.
(DOI: 10.1210/jc.2013-3430,   PubMed: 24297799)
40. Rika Jimbo, Fumiko Kawakami-Mori, Shengyu Mu, Daigoro Hirohama, Bohumil Majtan, Yuichiro Shimizu, Yutaka Yatomi, Seiji Fukumoto, Toshiro Fujita and Tatsuo Shimosawa :
Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.,
Kidney International, Vol.85, No.5, 1103-1111, 2013.
(DOI: 10.1038/ki.2013.332,   PubMed: 24088960)
41. Takaaki Okamoto, Manabu Taguchi, Tomoko Osaki, Seiji Fukumoto and Toshiro Fujita :
Phosphate enhances reactive oxygen species production and suppresses osteoblastic differentiation.,
Journal of Bone and Mineral Metabolism, Vol.32, No.4, 393-399, 2013.
(DOI: 10.1007/s00774-013-0516-z,   PubMed: 24052209)
42. Masafumi Fukagawa, Keitaro Yokoyama, Fumihiko Koiwa, Masatomo Taniguchi, Tetsuo Shoji, James Junichiro Kazama, Hirotaka Komaba, Ryoichi Ando, Takatoshi Kakuta, Hideki Fujii, Msasaaki Nakayama, Yugo Shibagaki, Seiji Fukumoto, Naohiko Fujii, Motoshi Hattori, Akira Ashida, Kunitoshi Iseki, Takashi Shigematsu, Yusuke Tsukamoto, Yoshiharu Tsubakihara, Tadashi Tomo, Hideki Hirakata and Tadao Akizawa :
Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.,
Therapeutic Apheresis and Dialysis, Vol.17, No.3, 247-288, 2013.
(DOI: 10.1111/1744-9987.12058,   PubMed: 23735142)
43. Kate Vandyke, Stephen Fitter, Jenny Drew, Seiji Fukumoto, G Christopher Schultz, A Natalie Sims, T David Yeung, P Timothy Hughes and W Andrew C Zannettino :
Prospective histomorphometric and DXA evaluation of bone remodeling in imatinib-treated CML patients: evidence for site-specific skeletal effects.,
The Journal of Clinical Endocrinology and Metabolism, Vol.98, No.1, 67-76, 2012.
(DOI: 10.1210/jc.2012-2426,   PubMed: 23144472)
44. Sunao Yamamoto, Yosuke Okada, Hiroko Mori, Seiji Fukumoto and Yoshiya Tanaka :
Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.,
Internal Medicine, Vol.51, No.17, 2375-2378, 2012.
(DOI: 10.2169/internalmedicine.51.7450,   PubMed: 22975552)
45. Hiroo Kawarazaki, Yugo Shibagaki, Ryo Kido, Ichiro Nakajima, Shohei Fuchinoue, Katsuyuki Ando, Toshiro Fujita, Masafumi Fukagawa, Satoshi Teraoka and Seiji Fukumoto :
Kidney transplantation restored uncoupled bone turnover in end-stage renal disease.,
Clinical Nephrology, Vol.78, No.1, 10-16, 2012.
(DOI: 10.5414/cn107348,   PubMed: 22732332)
46. Yuka Kinoshita, Tasuku Saito, Yuichiro Shimizu, Michiko Hori, Manabu Taguchi, Takashi Igarashi, Seiji Fukumoto and Toshiro Fujita :
Mutational analysis of patients with FGF23-related hypophosphatemic rickets.,
European Journal of Endocrinology, Vol.167, No.2, 165-172, 2012.
(DOI: 10.1530/EJE-12-0071,   PubMed: 22577109)
47. Takashi Shimada and Seiji Fukumoto :
FGF23 as a novel therapeutic target.,
Advances in Experimental Medicine and Biology, Vol.728, 158-170, 2012.
(DOI: 10.1007/978-1-4614-0887-1_10,   PubMed: 22396168)
48. Yukiko Aono, Hisashi Hasegawa, Yuji Yamazaki, Takashi Shimada, Toshiro Fujita, Takeyoshi Yamashita and Seiji Fukumoto :
Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice.,
Journal of Bone and Mineral Research, Vol.26, No.4, 803-810, 2011.
(DOI: 10.1002/jbmr.275,   PubMed: 20939065)
49. Hisashi Hasegawa, Nobuo Nagano, Itaru Urakawa, Yuji Yamazaki, Kousuke Iijima, Toshiro Fujita, Takeyoshi Yamashita, Seiji Fukumoto and Takashi Shimada :
Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.,
Kidney International, Vol.78, No.10, 975-980, 2010.
(DOI: 10.1038/ki.2010.313,   PubMed: 20844473)
50. Hiroyuki Inose, Hiroki Ochi, Ayako Kimura, Koji Fujita, Ren Xu, Shingo Sato, Makiko Iwasaki, Satoko Sunamura, Yasuhiro Takeuchi, Seiji Fukumoto, Kuniaki Saito, Takashi Nakamura, Haruhiko Siomi, Hiroshi Ito, Yoshiyasu Arai, Ken-ichi Shinomiya and Shu Takeda :
A microRNA regulatory mechanism of osteoblast differentiation.,
Proceedings of the National Academy of Sciences of the United States of America, Vol.106, No.49, 20794-20799, 2009.
(DOI: 10.1073/pnas.0909311106,   PubMed: 19933329)
51. Yukiko Aono, Yuji Yamazaki, Junichi Yasutake, Takehisa Kawata, Hisashi Hasegawa, Itaru Urakawa, Toshiro Fujita, Michihito Wada, Takeyoshi Yamashita, Seiji Fukumoto and Takashi Shimada :
Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia.,
Journal of Bone and Mineral Research, Vol.24, No.11, 1879-1888, 2009.
(DOI: 10.1359/jbmr.090509,   PubMed: 19419316)
52. Tasuku Saito, Yutaka Nishii, Toshiyuki Yasuda, Nobuaki Ito, Hisanori Suzuki, Takashi Igarashi, Seiji Fukumoto and Toshiro Fujita :
Familial hypophosphatemic rickets caused by a large deletion in PHEX gene.,
European Journal of Endocrinology, Vol.161, No.4, 647-651, 2009.
(DOI: 10.1530/EJE-09-0261,   PubMed: 19581284)
53. Yuichiro Shimizu, Yuko Tada, Mika Yamauchi, Takaaki Okamoto, Hisanori Suzuki, Nobuaki Ito, Seiji Fukumoto, Toshitsugu Sugimoto and Toshiro Fujita :
Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.,
Bone, Vol.45, No.4, 814-816, 2009.
(DOI: 10.1016/j.bone.2009.06.017,   PubMed: 19555782)
54. Yuji Yamazaki, Taro Tamada, Noriyuki Kasai, Itaru Urakawa, Yukiko Aono, Hisashi Hasegawa, Toshiro Fujita, Ryota Kuroki, Takeyoshi Yamashita, Seiji Fukumoto and Takashi Shimada :
Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.,
Journal of Bone and Mineral Research, Vol.23, No.9, 1509-1518, 2008.
(DOI: 10.1359/jbmr.080417,   PubMed: 18442315)
55. Itsuro Endo, Seiji Fukumoto, Keiichi Ozono, Noriyuki Namba, Hiroyuki Tanaka, Daisuke Inoue, Masanori Minagawa, Toshitsugu Sugimoto, Mika Yamauchi, Toshimi Michigami and Toshio Matsumoto :
Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.,
Bone, Vol.42, No.6, 1235-1239, 2008.
(DOI: 10.1016/j.bone.2008.02.014,   PubMed: 18396126)
56. Yaacov Frishberg, Nobuaki Ito, Choni Rinat, Yuji Yamazaki, Sofia Feinstein, Itaru Urakawa, Paulina Navon-Elkan, Rachel Becker-Cohen, Takeyoshi Yamashita, Kaori Araya, Takashi Igarashi, Toshiro Fujita and Seiji Fukumoto :
Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23.,
Journal of Bone and Mineral Research, Vol.22, No.2, 235-242, 2007.
(DOI: 10.1359/jbmr.061105,   PubMed: 17129170)
57. Itaru Urakawa, Yuji Yamazaki, Takashi Shimada, Kousuke Iijima, Hisashi Hasegawa, Katsuya Okawa, Toshiro Fujita, Seiji Fukumoto and Takeyoshi Yamashita :
Klotho converts canonical FGF receptor into a specific receptor for FGF23.,
Nature, Vol.444, No.7120, 770-774, 2006.
(DOI: 10.1038/nature05315,   PubMed: 17086194)
58. Kaori Araya, Seiji Fukumoto, Rebecca Backenroth, Yasuhiro Takeuchi, Kounosuke Nakayama, Nobuaki Ito, Nozomi Yoshii, Yuji Yamazaki, Takeyoshi Yamashita, Justin Silver, Takashi Igarashi and Toshiro Fujita :
A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.,
The Journal of Clinical Endocrinology and Metabolism, Vol.90, No.10, 5523-5527, 2005.
(DOI: 10.1210/jc.2005-0301,   PubMed: 16030159)
59. Takashi Shimada, Yuji Yamazaki, Motoo Takahashi, Hisashi Hasegawa, Itaru Urakawa, Takeshi Oshima, Kaori Ono, Makoto Kakitani, Kazuma Tomizuka, Toshiro Fujita, Seiji Fukumoto and Takeyoshi Yamashita :
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.,
American Journal of Physiology, Renal Physiology, Vol.289, No.5, F1088-95, 2005.
(DOI: 10.1152/ajprenal.00474.2004,   PubMed: 15998839)
60. Sumiyo Watanabe, Seiji Fukumoto, Hangil Chang, Yasuhiro Takeuchi, Yukihiro Hasegawa, Ryo Okazaki, Noriko Chikatsu and Toshiro Fujita :
Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.,
The Lancet, Vol.360, No.9334, 692-694, 2002.
(DOI: 10.1016/S0140-6736(02)09842-2,   PubMed: 12241879)
61. T Shimada, S Mizutani, T Muto, T Yoneya, R Hino, S Takeda, Y Takeuchi, T Fujita, Seiji Fukumoto and T Yamashita :
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.,
Proceedings of the National Academy of Sciences of the United States of America, Vol.98, No.11, 6500-6505, 2001.
(DOI: 10.1073/pnas.101545198,   PubMed: 11344269,   Elsevier: Scopus)

Review, Commentary:

1. Seiji Fukumoto :
Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?,
Frontiers in Endocrinology, Vol.9, 48, Feb. 2018.
(Tokushima University Institutional Repository: 112959,   DOI: 10.3389/fendo.2018.00048,   PubMed: 29515522)
2. Yuka Kinoshita and Seiji Fukumoto :
X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases -Prospect for new treatment.,
Endocrine Reviews, Vol.39, No.3, 274-291, Jan. 2018.
(DOI: 10.1210/er.2017-00220,   PubMed: 29381780,   Elsevier: Scopus)
3. Seiji Fukumoto :
[Aging and homeostasis. Calcium metabolism and aging.],
Clinical Calcium, Vol.27, No.7, 941-945, Jul. 2017.
(PubMed: 28649099)
4. Seiji Fukumoto and Toshio Matsumoto :
Recent advances in the management of osteoporosis.,
F1000Research, Vol.6, 625, May 2017.
(DOI: 10.12688/f1000research.10682.1,   PubMed: 28529724)
5. Ryo Okazaki, Keiichi Ozono, Seiji Fukumoto, Daisuke Inoue, Mika Yamauchi, Masanori Minagawa, Toshimi Michigami, Yasuhiro Takeuchi, Toshio Matsumoto and Toshitsugu Sugimoto :
Assessment criteria for vitamin D deficiency/insufficiency in Japan - proposal by an expert panel supported by Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society [Opinion].,
Endocrine Journal, Vol.64, No.1, 1-6, Dec. 2016.
(DOI: 10.1507/endocrj.EJ16-0548,   PubMed: 28003569)
6. Ryo Okazaki, Keiichi Ozono, Seiji Fukumoto, Daisuke Inoue, Mika Yamauchi, Masanori Minagawa, Toshimi Michigami, Yasuhiro Takeuchi, Toshio Matsumoto and Toshitsugu Sugimoto :
Assessment criteria for vitamin D deficiency/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion].,
Journal of Bone and Mineral Metabolism, Vol.35, No.1, 1-5, Nov. 2016.
(DOI: 10.1007/s00774-016-0805-4,   PubMed: 27882481)
7. Seiji Fukumoto, Keiichi Ozono, Toshimi Michigami, Masanori Minagawa, Ryo Okazaki, Toshitsugu Sugimoto, Yasuhiro Takeuchi and Toshio Matsumoto :
Pathogenesis and diagnostic criteria for rickets and osteomalacia - proposal by an expert panel supported by Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society.,
Endocrine Journal, Vol.62, No.8, 665-671, Jul. 2015.
(DOI: 10.1507/endocrj.EJ15-0289,   PubMed: 26156530)

Proceeding of International Conference:

1. Seiji Fukumoto :
FGF23-related hypophosphatemic diseases: Prospect for new treatment,
SfE BES 2019, Brighton, Nov. 2019.
2. Maria Tsoumpra, Michihiro Imamura, Yoshitaka Mizobe, Shin'ichi Takeda, Yoshitsugu Aoki, Seiji Fukumoto and Toshio Matsumoto :
The vitamin D - vitamin D receptor axis positively regulates the expression of dystrobrevin alpha during murine myogenic differentiation,
ASBMR 2019, Orlando, Sep. 2019.
3. Minae Koga, Hajime Kato, Nobuaki Ito, Yuka Kinoshita and Seiji Fukumoto :
The utility of SRS/SRPET and systemic FG23 venous sampling for tumor localization in 20 consecutive tumor-induced osteomalacia cases,
ASBMR 2019, Orlando, Sep. 2019.
4. Mai Kanai, Itsuro Endo, Yasuko Takahashi, Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
Establishment of model mice of FGF23-related hypophosphatemia induced by iron solution administration,
ASBMR 2019, Orlando, Sep. 2019.
5. Seiji Fukumoto :
Hypophosphatemic rickets/osteomalacia -Pathogenesis and new treatment-,
The 7th Seoul Symposium on Bone Health, Seoul, May 2019.
6. Seiji Fukumoto :
New insights into the FGF23 health and disease,
ECTS 2019, Budapest, May 2019.
7. Seiji Fukumoto :
Regulatory mechanism of phosphate metabolism,
9th International Conference on Osteoporosis and Bone Research, 2018, Oct. 2018.
8. Itsuro Endo, Bingzi Dong, Yukiyo Ohnishi, Yukari Ooguro, Kurahashi Kiyoe, Hiasa Masahiro, Junpei Teramachi, Tenshin Hirofumi, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
Persistent activation of calcium-sensing receptor increases microcrack and decreases bone strength,
ASBMR 2018 Annual Meeting, Mnrtial, QU, Oct. 2018.
9. Nobuaki Ito, Yasuo Imanishi, Yasuhiro Takeuchi, Yutaka Takahashi, Y Rhee, CS Shin, H Kanda and Seiji Fukumoto :
Effects of burosumab, an anti-FGF23 antibody, in patients with tumor-induced osteomalacia: Resuults from an ongoing phase 2 study,
ASBMR2018, Sep. 2018.
10. Yuichi Takashi, Yuka Kinoshita, Nobuaki Ito, Shun Sawatsubashi, Hidetaka Kosako, Masahiro Abe, Munehide Matsuhisa, Toshio Matsumoto and Seiji Fukumoto :
FGF receptor 1c works as a phosphate-sensor to regulate FGF23 production,
ASBMR 2018 Annual Meeting Registration Confirmation, Sep. 2018.
11. Seiji Fukumoto :
The Biology of FGF23,
Keystone Symposia - Novel Aspects of Bone Biology, Jun. 2018.
12. Sumiko Yoshida, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe :
Changes of oxidative stress markers in patient of diabetes educational hospitalization.,
The Endocrine Society's Annual Meeting 2018, Chicago, Mar. 2018.
13. Kana Morimoto, Masuda Shiho, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Akehi Yuko, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Ken-ichi Aihara :
Identification of clinical determinants for coefficient of variation of - intervals in patients with type 2 diabetes.,
International Conference on Diabetes and Its Complications 2017, Baltimore, Nov. 2017.
14. Itsuro Endo, Dong Bingzi, Ohnishi Yukiyo, Kondo Takeshi, Masahiro Hiasa, Jumpei Teramachi, Toshio Matsumoto, Masahiro Abe, Seiji Fukumoto and Tatsuji Haneji :
Decreased bone strength induced by persistent activation of calcium-sensing receptor,
American Society for Bone and Mineral Research (ASBMR) 2017 Annual Meeting, Denver, Sep. 2017.
15. Kiyoe Kurahashi, Itsuro Endo, Nakamura Maiko, Ohnishi Yukiyo, Takeshi Kondo, Aizawa Shinichi, Toshio Matsumoto, Seiji Fukumoto and Masahiro Abe :
Glucose intolerance induced by persistent activation of calcium-sensing receptor,
American Society for Bone and Mineral Research 2016 Annual Meeting, Atlanta, Sep. 2016.
16. Itsuro Endo, Seiji Fukumoto and Toshio Matsumoto :
FGF23-related hypophosphatemic diseases in Japan.,
oint Meeting of International Bone and Mineral Society and The Japanese Society of Bone Mineral Research, Jul. 2011.

Proceeding of Domestic Conference:

1. Seiji Fukumoto :
骨粗鬆症の最新治療-多様な治療薬の作用と選択-,
第29回臨床内分泌代謝Update in Kochi, Nov. 2019.
2. Seiji Fukumoto :
骨・ミネラル代謝と内分泌学,
Skeletal Science Retreat, Nov. 2019.
3. Seiji Fukumoto :
癌治療関連骨減少症の管理,
第38回日本骨代謝学会学術集会, Oct. 2019.
4. Seiji Fukumoto :
骨形成促進薬としてのアバロパラチド,
第21回日本骨粗鬆症学会, Oct. 2019.
5. Seiji Fukumoto :
FGF23とリン代謝,
第49会日本腎臓学会東部学術大会, Oct. 2019.
6. 辻本 賀美, 三井 由加里, 工藤 千晶, 安井 沙耶, 遠藤 ふうり, 桝田 志保, Kiyoe Kurahashi, Sumiko Yoshida, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe and Seiji Fukumoto :
勤務時間の影響で副腎皮質機能異常が疑われた2例,
日本内分泌学会第19回四国支部学術集会, Sep. 2019.
7. 工藤 千晶, 枡田 志保, 辻本 賀美, 安井 沙耶, 遠藤 ふうり, 三井 由加里, Kiyoe Kurahashi, Sumiko Yoshida, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe, 新谷 保実 and Seiji Fukumoto :
両側副腎偶発腫瘍で発見された123I-MIBGシンチ陰性の褐色細胞腫の一例,
日本内分泌学会第19回四国支部学術集会, Sep. 2019.
8. 安井 沙耶, 桝田 志保, Sumiko Yoshida, 辻本 賀美, 工藤 千晶, 遠藤 ふうり, 三井 由加里, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto :
成長ホルモン分泌不全症と甲状腺機能低下症を呈した小児がん経験者の一例,
第259回 徳島医学会学術集会(令和元年度夏期), Aug. 2019.
9. Seiji Fukumoto :
ミネラル代謝異常症診療の進歩,
一般社団法人日本骨代謝学会 教育講演会, Jul. 2019.
10. 宮高 絋輔, Sumiko Yoshida, Furi Endo, 枡田 志保, 三井 由加里, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Makoto Funaki, Yoshihiro Matsudate, Hiroshi Nokihara, Yasuhiko Nishioka, Masahiro Abe and Munehide Matsuhisa :
免疫チェックポイント阻害薬投与後に1型糖尿病を発症した2例,
第62回日本糖尿病学会年次学術集会, May 2019.
11. Mai Kanai, 松岡 飛翔, Itsuro Endo, 大西 幸代, Yuichi Takashi, Kiyoe Kurahashi, Sumiko Yoshida, Ken-ichi Aihara, Masahiro Abe, Seiji Fukumoto and Toshio Matsumoto :
鉄製剤投与によるFGF23関連低リン血症モデル作成の試み,
日本内分泌学会雑誌, Vol.95, No.1, 422, May 2019.
12. Yuichi Takashi, Hidetaka Kosako, Shun Sawatsubashi, Yuka Kinoshita, 伊東 伸朗, Masahiro Abe, Munehide Matsuhisa, Shigeaki Kato, Toshio Matsumoto and Seiji Fukumoto :
FGFR1はFGF23濃度調節を媒介するリン感知受容体である,
日本内分泌学会雑誌, Vol.95, No.1, 333, May 2019.
13. Seiji Fukumoto :
FGF23関連低リン血症性疾患患者の治療,
第92回日本内分泌学会学術総会, May 2019.
14. Kohsuke Miyataka, Furi Endo, 三井 由加里, 枡田 志保, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Hiroshi Nokihara, Yasuhiko Nishioka, Masahiro Abe and Munehide Matsuhisa :
抗PD-1抗体投与後に1型糖尿病を発症した1例,
第258回徳島医学会学術集会 ポスターセッション, Feb. 2019.
15. Sumiko Yoshida, 原 倫世, 山口 佑樹, Takeshi Kondo, 遠藤 ふうり, 筒井 康継, 桝田 志保, Kiyoe Kurahashi, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Masahiro Abe, Kohhei Nakajima and Seiji Fukumoto :
急速に腫瘍が増大し悪性転化が疑われたCushing病の1例,
第28回臨床内分泌代謝Update, Nov. 2018.
16. Seiji Fukumoto :
CTIBL,
第20回日本骨粗鬆症学会, Oct. 2018.
17. Seiji Fukumoto :
ビタミンDの作用と骨粗鬆症,
第20回日本骨粗鬆症学会, Oct. 2018.
18. Seiji Fukumoto :
癌治療に伴う骨粗鬆症に対する薬物療法,
第20回日本骨粗鬆症学会, Oct. 2018.
19. Seiji Fukumoto :
腫瘍性骨軟化症(tumor-induced ostomalacia: TIO)の病因,
第22回日本臨床内分泌病理学会学術総会, Sep. 2018.
20. Seiji Fukumoto :
腫瘍性骨軟化症(tumor-induced ostomalacia: TIO)の病因,
第22回日本臨床内分泌病理学会学術総会, Sep. 2018.
21. Kiyoe Kurahashi, Itsuro Endo, Takeshi Kondo, 遠藤 ふうり, 原 倫世, 桝田 志保, Sumiko Yoshida, 明比 祐子, Yoshimi Bando, Ken-ichi Aihara, Masahiro Abe and Seiji Fukumoto :
ソマトスタチンアナログ製剤にて著明な縮小がみられたGH産生マクロアデノーマの1例,
第22回 日本臨床内分泌病理学会, Sep. 2018.
22. 原 倫世, Sumiko Yoshida, 細井 美希, 遠藤 ふうり, 筒井 康継, 桝田 志保, Kiyoe Kurahashi, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Kohhei Nakajima, Yoshimi Bando, Masahiro Abe and Seiji Fukumoto :
脳内,副鼻腔,下垂体に炎症を認めステロイドが著効した1例,
第22回日本臨床内分泌病理学会, Sep. 2018.
23. Kiyoe Kurahashi, Furi Endo, 桝田 志保, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Seiji Fukumoto, Itsuro Endo and Munehide Matsuhisa :
足趾上腕血圧比定値を契機に末梢動脈疾患を診断しえた,重症下肢軟部組織感染症を繰り返す2型糖尿病の一例,
第3回日本下肢救済・足病学会中国四国地方会学術集会, Sep. 2018.
24. 桝田 志保, Itsuro Endo, 遠藤 ふうり, 原 倫世, 筒井 康継, Kiyoe Kurahashi, Sumiko Yoshida, Tomoteru Kishimoto, Ken-ichi Aihara and Seiji Fukumoto :
hCG,FSH製剤の併用によりパートナーの妊娠が確認された低ゴナドトロピン性男性性腺機能低下症の2例,
第18回日本内分泌学会四国支部学術集会, Sep. 2018.
25. 中村 昌史, 原 倫世, Kiyoe Kurahashi, 遠藤 ふうり, 筒井 康継, 桝田 志保, Sumiko Yoshida, 明比 祐子, Itsuro Endo and Seiji Fukumoto :
股関節痛と歩行困難を契機に診断したCushing症候群の一例,
第18回日本内分泌学会四国支部学術集会, Sep. 2018.
26. Yuichi Takashi, Masashi Ishizu, 脇野 修, 水口 斉, 島久 登, 田代 学, 宮 恵子, 水口 潤, Akio Kuroda, Toshio Matsumoto, Munehide Matsuhisa and Seiji Fukumoto :
血液透析患者における心不全・動脈硬化・感染のリスク因子としてのFGF23,
第18回日本内分泌学会四国支部学術集会, Sep. 2018.
27. Ken-ichi Aihara, Sumiko Yoshida, Furi Endo, 筒井 康継, Tomoyo Hara, 桝田 志保, Kiyoe Kurahashi, Toshiki Otoda, Tomoyuki Yuasa, Itsuro Endo, Kana Morimoto, Akio Kuroda, 明比 祐子, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe :
原発性アルドステロン症におけるミネラルコルチコイド受容体拮抗薬の血管機能への影響,
第18回日本内分泌学会四国支部学術集会, Sep. 2018.
28. 山上 紘規, Sumiko Yoshida, 遠藤 ふうり, 原 倫世, 筒井 康継, 桝田 志保, Kiyoe Kurahashi, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Yusuke Osaki, Ryuji Kaji, Yuichi Takashi, Masahiro Abe and Seiji Fukumoto :
壊死性ミオパチーを合併したX連鎖性低リン血症性くる病・骨軟化症の一例,
第18回日本内分泌学会四国支部学術集会, Sep. 2018.
29. Itsuro Endo, 大西 幸代, Kiyoe Kurahashi, Jumpei Teramachi, Masahiro Hiasa, Hirofumi Tenshin, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
カルシウム感知受容体活性型変異マウスにおける骨強度の低下,
第36回日本骨粗鬆症学会各術集会, Jul. 2018.
30. Seiji Fukumoto :
FGF23∼臨床から基礎へ,そして未来へ∼,
第63回日本透析医学会学術集会・総会, Jul. 2018.
31. Sumiko Yoshida, 原 倫世, 細井 美希, 山上 紘規, 山口 佑樹, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa :
糖尿病教育入院における筋肉量の変化,
第61回日本糖尿病学会年次学術集会, May 2018.
32. 山上 紘規, Sumiko Yoshida, 原 倫世, 細井 美希, 山口 佑樹, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Masahiro Abe, Yoshihiro Matsudate and Munehide Matsuhisa :
免疫チェックポイント阻害薬投与後に甲状腺機能異常と劇症1型糖尿病を発症した1例,
第61回日本糖尿病学会年次学術集会, May 2018.
33. Masashi Ishizu, Yuichi Takashi, 脇野 修, 水口 斉, 田代 学, 宮 恵子, Yoshihiko Noma, 小松 まち子, 水口 潤, Akio Kuroda, Seiji Fukumoto and Munehide Matsuhisa :
血液透析患者における糖尿病をはじめとする動脈硬化リスク因子の検討,
第61回日本糖尿病学会年次学術集会, May 2018.
34. Motoyuki Tamaki, Yuichi Takashi, Toshiki Otoda, Seiji Fukumoto, Akio Kuroda, 明比 祐子, Hiroyasu Mori, Satoshi Taniguchi, 鈴木 麗子, Misuzu Yamada, Masashi Ishizu, Mami Ohishi, 白神 敦久, Ken-ichi Aihara, Makoto Funaki and Munehide Matsuhisa :
かかりつけ患者に対するSGLT2阻害薬の投与開始タイミングの特徴と投与開始後の体重・eGFR・ALT・脂質代謝の変化,
第61回日本糖尿病学会年次学術集会, May 2018.
35. Ken-ichi Aihara, 上元 良子, 石川 カズ江, Kana Morimoto, 桝田 志保, Hiroki Yamagami, Yuki Yamaguchi, Tomoyo Hara, 細井 美希, Kiyoe Kurahashi, Sumiko Yoshida, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa, Hiroyuki Azuma and Masahiro Abe :
生活習慣病患者の尿中酸化ストレス指標における糖尿病および薬物療法の影響,
第61回日本糖尿病学会年次学術集会, May 2018.
36. Itsuro Endo, Dong Bingzi, Ohnishi Yukiyo, Sumiko Yoshida, Ken-ichi Aihara, 相澤 慎一, Seiji Fukumoto, Masahiro Abe and Toshio Matsumoto :
常染色体優性低Ca血症1型モデルマウスにおける骨強度の低下,
第91回日本内分泌学会学術総会, Apr. 2018.
37. Seiji Fukumoto :
FGF23にようるミネラル代謝調節機構,
第91回日本内分泌学会学術総会, Apr. 2018.
38. Sumiko Yoshida, 原 倫世, 細井 美希, 山上 紘規, 山口 佑樹, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Seiji Fukumoto, Daisuke Hamada, Munehide Matsuhisa and Masahiro Abe :
待機的高リスク整形外科手術における血糖管理の効果,
第91回日本内分泌学会学術総会, Apr. 2018.
39. Seiji Fukumoto :
抗スクレロスチン抗体,
第2回日本CKD-MBD研究会学術集会・総会, Mar. 2018.
40. 山上 紘規, Kiyoe Kurahashi, 原 倫世, 細井 美希, 山口 佑樹, 桝田 志保, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara and Seiji Fukumoto :
副腎クリーゼと急性膵炎を発症した21‐水酸化酵素欠損症の1例,
第117回日本内科学会四国地方会, Nov. 2017.
41. 原 倫世, Sumiko Yoshida, 山上 紘規, 山口 佑樹, 細井 美希, 桝田 志保, Kiyoe Kurahashi, Itsuro Endo, 明比 祐子, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki and Seiji Fukumoto :
Frequent syncope and marked blood pressure fluctuation due to antiparkinson drugs: A case report,
2017年10月20日-22日 ひめぎんホール, Oct. 2017.
42. 山上 紘規, Kiyoe Kurahashi, 山口 佑樹, 細井 美希, 原 倫世, 桝田 志保, Sumiko Yoshida, Itsuro Endo, 明比 祐子, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki and Seiji Fukumoto :
バセドウ病とTSH産生下垂体腺腫の合併の一例,
第60回日本甲状腺学会学術集会, Oct. 2017.
43. 細井 美希, Sumiko Yoshida, 山上 紘規, 山口 佑樹, 原 倫世, 桝田 志保, Kiyoe Kurahashi, Itsuro Endo, 明比 祐子, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki and Seiji Fukumoto :
無セルロプラスミン血症に合併した甲状腺乳頭癌の一例,
第60回日本甲状腺学会学術集会, Oct. 2017.
44. 山口 佑樹, Sumiko Yoshida, 細井 美希, 山上 紘規, 原 倫世, 桝田 志保, Kiyoe Kurahashi, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Munehide Matsuhisa, Makoto Funaki, Seiji Fukumoto and Hiromitsu Takizawa :
当院での免疫チェックポインント阻害薬による内分泌異常の発生と有害事象対策,
第255回徳島医学会学術集会(平成29年度夏期), Aug. 2017.
45. Kana Morimoto, 桝田 志保, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Seiji Fukumoto, Munehide Matsuhisa, Masahiro Abe, Hiroyuki Azuma and Ken-ichi Aihara :
生活習慣病患者における血管内皮機能制御に関わる臨床指標の検討,
第49回日本動脈硬化学会総会・学術集会, Jul. 2017.
46. 西山 美月, Kiyoe Kurahashi, 桝田 志保, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, 小松 まち子, Seiji Fukumoto and Masahiro Abe :
維持透析中に管理困難な高Ca血症を契機に診断されたサルコイドーシスの一例,
第116回日本内科学会四国地方会, May 2017.
47. Sumiko Yoshida, Ken-ichi Aihara, Kiyoe Kurahashi, Takeshi Kondo, Itsuro Endo, Tomoyuki Yuasa, Seiji Fukumoto and Masahiro Abe :
骨格筋におけるアンドロゲン受容体の耐糖能への影響,
第90回日本内分泌学会学術総会, Apr. 2017.
48. 桝田 志保, Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Itsuro Endo, Masahiro Abe, Akio Kuroda, Munehide Matsuhisa, Ken-ichi Aihara and Seiji Fukumoto :
メーグルコシダーゼ阻害薬による腸管気腫症の一例,
第115回日本内科学会四国地方会, Nov. 2016.
49. 原 倫世, Kiyoe Kurahashi, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Akio Kuroda, Munehide Matsuhisa, Ken-ichi Aihara and Seiji Fukumoto :
イピリムマブ投与後に続発性副腎不全を発症した一例,
第115回日本内科学会四国地方会, Nov. 2016.
50. 上田 浩之, Itsuro Endo, Takeshi Kondo, Kiyoe Kurahashi, Sumiko Yoshida, Masahiro Abe, Akio Kuroda, Munehide Matsuhisa, Ken-ichi Aihara and Seiji Fukumoto :
デノスマブによる耐糖能改善,
第115回日本内科学会四国地方会, Nov. 2016.
51. Takeshi Kondo, Itsuro Endo, 明比 祐子, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Masahiro Abe and Seiji Fukumoto :
免疫チェックポイント阻害剤で中枢性副腎不全を来した2例,
第26回臨床内分泌代謝Update, Nov. 2016.
52. 岡本 恵暢, Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Kana Morimoto, Motoyuki Tamaki, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Munehide Matsuhisa and Seiji Fukumoto :
IGF-2産生神経内分泌癌による重症低血糖の一例,
第26回臨床内分泌代謝Update, Nov. 2016.
53. Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Kana Morimoto, Motoyuki Tamaki, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Makoto Funaki, Munehide Matsuhisa and Seiji Fukumoto :
当院のニボルマブおよびイピリムマブ投与21例の内分泌異常の検討,
第26回臨床内分泌代謝Update, Nov. 2016.
54. 山下 沙織, Sumiko Yoshida, 高橋 優花, Ken-ichi Aihara, Kiyoe Kurahashi, Takeshi Kondo, Kana Morimoto, Motoyuki Tamaki, Tomoyuki Yuasa, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe :
糖尿病教育入院における酸化ストレス減少に影響を及ぼす因子の検討,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
55. 荒瀬 美晴, Takeshi Kondo, Akio Kuroda, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa :
術前後で持続血糖モニター(CGM)を比較したアドレナリン優位褐色細胞腫の二例,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
56. 上田 浩之, Takeshi Kondo, Akio Kuroda, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto, Masahiro Abe and Munehide Matsuhisa :
基礎インスリンが不要であった膵性糖尿病の一例,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
57. Kana Morimoto, 桝田 志保, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Sumiko Yoshida, Tomoyuki Yuasa, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara :
糖尿病患者における心電図R-R間隔変動係数に影響を及ぼす因子の検討,
日本糖尿病学会中国四国地方会第54回総会, Nov. 2016.
58. 高橋 優花, 山下 沙織, Sumiko Yoshida, 桝田 志保, Kana Morimoto, Kiyoe Kurahashi, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Tomoyuki Yuasa, Itsuro Endo, Munehide Matsuhisa, Seiji Fukumoto, Hiroyuki Azuma, Masahiro Abe and Ken-ichi Aihara :
生活習慣病患者における血管内皮機能正常群および低下群の臨床指標に関する検討,
第16回日本内分泌学会四国支部学術集会, Sep. 2016.
59. 山上 紘規, Kiyoe Kurahashi, Kana Morimoto, Takeshi Kondo, Itsuro Endo, 明比 祐子, Sumiko Yoshida, Akio Kuroda, Ken-ichi Aihara, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe :
バセドウ病を合併したTSH産生下垂体腺腫の一例,
第16回日本内分泌学会四国支部学術集会, Sep. 2016.
60. 遠藤 ふうり, Kiyoe Kurahashi, Kana Morimoto, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Akio Kuroda, 明比 祐子, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe :
日和見感染を合併したACTH依存性Cushing症候群の1例,
第253回徳島医学会学術集会(平成28年度夏期), Jul. 2016.
61. Kiyoe Kurahashi, Itsuro Endo, Nakamura Mayuko, Ohnishi Yukiyo, Takeshi Kondo, Aizawa Shinichi, Seiji Fukumoto and Masahiro Abe :
カルシウム感知受容体活性型変異による耐糖能異常,
第34回日本骨代謝学会学術総会, Jul. 2016.
62. Sumiko Yoshida, Ken-ichi Aihara, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, 明比 祐子, Makoto Funaki, Seiji Fukumoto and Munehide Matsuhisa :
当院検診受診者における筋肉量がメタボリックパラメーターに及ぼす影響の検討,
第59回日本糖尿病学会年次学術集会, May 2016.
63. Kana Morimoto, Ken-ichi Aihara, Sumiko Yoshida, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe :
減塩による2型糖尿病入院症例の 降圧予測指標,
第59回日本糖尿病学会年次学術集会, May 2016.
64. Sumiko Yoshida, Ken-ichi Aihara, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, Itsuro Endo, 明比 祐子, Makoto Funaki, Seiji Fukumoto and Munehide Matsuhisa :
当院検診受診者における筋肉量が高血圧に及ぼす影響の検討,
第5回臨床高血圧フォーラム, May 2016.
65. 山上 紘規, Kiyoe Kurahashi, 森本 佳奈, Takeshi Kondo, Sumiko Yoshida, Itsuro Endo, Ken-ichi Aihara, Akio Kuroda, 明比 祐子, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe :
インターフェロンβ治療中に糖尿病ケトアシドーシスを契機とし,急性発症1A型糖尿病と診断された一例,
第252回徳島医学会学術集会 長井記念ホール, Feb. 2016.
66. 林 亜紀, Takeshi Kondo, Itsuro Endo, Kiyoe Kurahashi, Sumiko Yoshida, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
オクトレオチドLARで画像上,下垂体腺腫が消失した先端巨大症の一例,
第113回日本内科学会四国地方会, Dec. 2015.
67. 森本 佳奈, Takeshi Kondo, Itsuro Endo, 倉橋 清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
著明な低カルシウム血症を来した胃癌の骨転移の一例,
第25回臨床内分泌Update, Nov. 2015.
68. 小山 広士, Takeshi Kondo, 森本 佳奈, Itsuro Endo, 倉橋 清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
ACTH,コルチゾール基礎値正常のACTH単独欠損症の一例,
第25回臨床内分泌Update, Nov. 2015.
69. Takeshi Kondo, Itsuro Endo, 森本 佳奈, 倉橋 清衛, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
テタニーで来院し,Gitelman症候群を疑った一例,
第25回臨床内分泌Update, Nov. 2015.
70. Ken-ichi Aihara, Sumiko Yoshida, Kana Morimoto, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe :
2型糖尿病患者の左室形態 および機能における 強化インスリン療法の効果,
日本糖尿病学会 第53回中国四国地方会, Oct. 2015.
71. 岡田 祐輝, Takeshi Kondo, 森本 佳奈, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
高CPR血症からグリメピリド誤内服を診断し得た遷延性低血糖の一例,
第53回日本糖尿病学会中国四国地方会 米子コンベンションセンター, Oct. 2015.
72. Ken-ichi Aihara, Sumiko Yoshida, 森本 佳奈, Kiyoe Kurahashi, Takeshi Kondo, Motoyuki Tamaki, Akio Kuroda, 明比 祐子, Itsuro Endo, Makoto Funaki, Seiji Fukumoto, Munehide Matsuhisa and Masahiro Abe :
2型糖尿病患者の左室形態および機能における強化インスリン療法の効果,
第53回日本糖尿病学会中国・四国地方会 米子コンベンションセンター, Oct. 2015.
73. 林 亜紀, Sumiko Yoshida, Akio Kuroda, 七篠 あつ子, Minoru Irahara, 鶴尾 美穂, 森本 佳奈, 倉橋 清衛, Takeshi Kondo, Motoyuki Tamaki, 明比 祐子, Itsuro Endo, Makoto Funaki, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
分娩前に10g/日以上の蛋白尿を合併し,出産に至った糖尿病腎症の1例,
日本糖尿病学会 中国四国地方会第53回総会, Oct. 2015.
74. 森本 佳奈, Takeshi Kondo, Itsuro Endo, Kiyoe Kurahashi, Motoyuki Tamaki, Sumiko Yoshida, Akio Kuroda, Munehide Matsuhisa, Seiji Fukumoto, Ken-ichi Aihara and Masahiro Abe :
診断まで長時間を要したACTH分泌低下症の一例,
第15回日本内分泌学会四国支部学術集会 高知大学, Sep. 2015.
75. 加藤 正樹, 森本 佳奈, Ken-ichi Aihara, Sumiko Yoshida, 倉橋 清衛, Motoyuki Tamaki, Takeshi Kondo, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Seiji Fukumoto and Masahiro Abe :
2型糖尿病患者の減塩療法による血圧低下に関連する因子の解析,
第15回 日本内分泌学会 四国支部学術集会, Sep. 2015.
76. Dong Bingzi, Itsuro Endo, Takeshi Kondo, 大西 幸代, Masahiro Abe, Seiji Fukumoto, 網塚 憲生, 長谷川 智香, 相澤 慎一 and Toshio Matsumoto :
常染色体優性低Ca血症モデルマウスに対するcalcilyticsの効果,
第32回日本骨代謝学会学術集会, Jul. 2014.
77. Itsuro Endo, Dong Bingzi, 長谷川 智香, 網塚 憲生, Seiji Fukumoto and Toshio Matsumoto :
Ca感知受容体関連疾患の最新の知見とその治療,
第87回日本内分泌学会, Apr. 2014.
78. Itsuro Endo, Seiji Fukumoto and Toshio Matsumoto :
FGF23関連低リン血症性疾患に対する全国疫学調査,
第84回日本内分泌学会学術総会, Apr. 2011.

Et cetera, Workshop:

1. 松田 宙也, 遠藤 ふうり, 三井 由加里, 桝田 志保, Kiyoe Kurahashi, Sumiko Yoshida, 明比 祐子, Itsuro Endo and Seiji Fukumoto :
症状発現から診断までに半年を要したACTH単独欠損症の一例,
第258回徳島医学会学術集会, Feb. 2019.
2. 宮高 紘輔, 遠藤 ふうり, 三井 由加里, 桝田 志保, Kiyoe Kurahashi, Sumiko Yoshida, Akio Kuroda, 明比 祐子, Itsuro Endo, Ken-ichi Aihara, Seiji Fukumoto and Munehide Matsuhisa :
抗PD-1抗体投与後に1型糖尿病を発症した1例,
第258回徳島医学会学術集会, Feb. 2019.
3. Itsuro Endo, 大西 幸代, 木戸 里佳, 倉橋 清衛, Yuichi Fujinaka, Ken-ichi Aihara, Sumiko Yoshida, Masahiro Abe, Seiji Fukumoto and Toshio Matsumoto :
Ca感知受容体機能に及ぼすcalcilyticsの作用,
第3回瀬戸内フォーラム, Aug. 2009.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

  • ファーストメッセンジャーとしてのリンの作用機序の解明 (Project/Area Number: 19H03676 )
  • Role and mechanism of action of IL-11 on the regulation of bone and adipose tissue interaction (Project/Area Number: 16H05327 )
  • Elucidation of molecular mechanism of the regulation of skeletal homeostasis, and development of new therapeutic approaches against skeletal disorders (Project/Area Number: 25293215 )
  • Analyses of oxidative stress Mechanisms in bone mineral disorders (Project/Area Number: 22591007 )
  • Regulatory mechanisms of mineral homeostasis by FGF23 (Project/Area Number: 21390284 )
  • Involvement of fibroblast growth factor 23 in bone and mineral metabolism and its disorders (Project/Area Number: 18390274 )
  • Physiological and pathological involvement of FGF-23 in mineral metabolism in human (Project/Area Number: 17590972 )
  • Regulation by adipocytokines of bone metabolism (Project/Area Number: 15590970 )
  • Research on regulatory mechanisms and their derangements of calcium and phosphate metabolism (Project/Area Number: 15390293 )
  • Role of bone marrow adipogenesis for bone formation and its abnormality in senile osteoporosis (Project/Area Number: 13671150 )
  • Elucidetion of pathogeness of derangements in Calcinm metabolism (Project/Area Number: 13671149 )
  • The mechanism of osteoblastic differentiotion regulated by BMP-dependent transcription factors-A basic study directed to development of a treatment for senile osteoporosis (Project/Area Number: 12671074 )
  • Study on signal transduction system through calcium-sensing receptor (Project/Area Number: 11671082 )
  • Cell-matrix interaction in the regulation of bone metabolism and its disorder in involutional osteoporosis (Project/Area Number: 11671081 )
  • Cell-matrix interaction in osteoblastic differentiation and its disorder in involutional osteoporosis (Project/Area Number: 09671031 )
  • Research on signal transduction through parathyroid hormone(PTH)/PTH-related protein receptor (Project/Area Number: 09671030 )
  • Regulation of osteoblastic differentiation and its implication in involutional osteoporosis (Project/Area Number: 07671111 )
  • Molecular biological analysis of signal transduction system through parathyroid hormone receptor. Evaluation of parathyroid hormone receptor in patients with pseudohypoparathyroidism. (Project/Area Number: 07671109 )
  • 偽性副甲状腺機能低下症患者における副甲状腺ホルモン受容変異の検討 (Project/Area Number: 06770798 )
  • Development of a new therapeutic approach for senile osteoporosis using bone matrix deoorin (Project/Area Number: 06557055 )
  • Role of matrix proteins in the local regulation of bone metabolism and its abonomalities in osteoporosis (Project/Area Number: 06454336 )
  • Search by Researcher Number (30202287)